BIODYNE Co., Ltd. engages in the development of cancer diagnosis solutions. Its products include liquid based cytology systems and consumable diagnostic kits. The company was founded on October 8, 1999 and is headquartered in Seoul, South Korea.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company